Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04928443
Other study ID # 202100112B0A3
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 15, 2021
Est. completion date June 20, 2022

Study information

Verified date June 2021
Source Chang Gung Memorial Hospital
Contact Chia-Hsieh Chang, Prof.
Phone 886-33281200
Email chiahchang@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Scar is an unpleasant symptom that commonly appear after orthopedic surgery, especially the joint procedure. Due to the wide motion range, skin around joint has excessive tension that may increase risk for wide or conspicuous scar formation of surgical wound. Noticeable scar can negatively impact the quality of life and psychosocial development. However, scar management is overlooked in early recovery period easily. Patients commonly start to turn their attention to the surgical scar after the completion of rehabilitation or the resolution of disease or unbearable symptom. It is always beyond the best period of scar treatment, 3 to 6 months after wound healing. This study is aimed to observe and evaluate the scar formation with or without aggressive management in pediatric population within 6 months after wound healing.


Description:

This is an observational, case-control study. Patients will be invited to participate and allocated to scar dressing group if they plan to use scar dressing. After gaining the written inform consent, participants will be asked to fulfill the patient diary, including the record of scar dressing use, patient scar assessment scale and satisfaction assessment, with parents' help. In regular group, patients are retrospectively selected by matched factors, such as demographics data. Scar-related data, including scar pictures, vancouver scar scale assessment and complication, are collected from medical history in both groups.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date June 20, 2022
Est. primary completion date December 20, 2021
Accepts healthy volunteers No
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria: 1. Aged 5 to 18 years 2. Had orthopedic surgery 3 weeks ago and within 6 weeks 3. Had incision sites around the knee 4. All surgical wounds healed completely 5. Length of surgical wounds between 2 and 15 centimeters 6. Planed to treat incisional scar with scar dressing, adhesive tapes, or adhesive strips Exclusion Criteria: 1. Surgical wound infection 2. Atopic dermatitis or sensitive skin 3. Not able to make return visits regularly 4. Participation was not appropriate determined by physician

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Scar dressing group
Patients treated with scar dressing for surgical scar care are invited to participate this study and allocated in scar dressing group despite the length of caring period.
Regular care group
Patients receiving regular scar care are retrospectively identified with matching factors, such as gender, age, length of surgical wound and surgical procedure.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Vancouver Scar Scale Vancouver scar scale includes four items toward evaluation of observable aspects of the scar. Each item is rated with 4-6 possible points. 3 months after surgical wound healing
Secondary Patient Scar Assessment Scale In scar dressing group, patient scar assessment scale consists of 6 questions. Each question is rated from 1 to 10. 1 is the best and 10 reflects the worst. From surgical wound healed to 6 months later
Secondary Incidence of incision site complication Percentage of the population suffering from surgical scar-related complications are analyzed, especially the ones toward scar dressing. From surgical wound healed to 6 months later
Secondary Patient satisfaction In scar dressing group, patients are asked with serial questions to rate satisfaction toward scar dressing on a numeric rating scale. 1 means the most unsatisfaction and 10 means the most satisfaction. 3 months after surgical wound healing
See also
  Status Clinical Trial Phase
Terminated NCT01883414 - Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars. N/A
Recruiting NCT01158196 - Safety and Efficacy of Infrared Diode Laser on Improvement of Scar and Prevention of Recurrence of Excised Keloid Phase 3
Completed NCT03467724 - Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift N/A
Completed NCT01789346 - Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars N/A